Release Date: 30/01/23 18:11 Summary: Quarterly Activities/Appendix 5B Cash Flow Report Price Sensitive: Yes Download Document 788.36KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%